RT Journal Article
SR Electronic
T1 Variation in colorectal cancer treatment and outcomes in Scotland: real world evidence from national linked administrative data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.28.22270027
DO 10.1101/2022.01.28.22270027
A1 Lemmon, E
A1 Hanna, C
A1 Diernberger, K
A1 Hall, PS
YR 2022
UL http://medrxiv.org/content/early/2022/03/28/2022.01.28.22270027.abstract
AB Background Colorectal cancer (CRC) is the third most common type of cancer in Scotland and the second leading cause of cancer death. Despite improvements in CRC survival over time, Scotland lags behind its UK and European counterparts. Linked administrative datasets can provide a real-world representation of current care as a basis for evaluation of new interventions or policies and to understand variation in care and outcomes. In this study, we aim to provide up to date, population level evidence on CRC treatment and survival in Scotland for patients treated with curative or palliative intent as a basis for the understanding of variation, and to provide data to underpin the evaluation of new treatments.Methods We conducted a retrospective analysis of adults with an incident CRC registered on the Scottish Cancer Registry (ICD-10 codes C18-20) between January 2006 and December 2018. Data on patients with incident CRC was linked to hospital inpatient records allowing description of their demographic, diagnostic and treatment characteristics. For a curative cohort (n = 26,204) Cox-Proportional Hazards regression models were used to assess the factors affecting overall survival (OS) and CRC specific survival (CRCS).Results Overall, 32,691 (73%) and 12,184 (27%) patients had a diagnosis of colon and rectal cancer respectively. On average, patients with colorectal cancer had two hospital inpatient stays in the five-years pre-diagnosis. Chemotherapy was used in 42% with colon cancer and 30% with colon cancer. Radiotherapy use was 2% and 39% respectively. Five year OS (CRCS) within the curative cohort was 71% (81%) and 75% (82%) for patients with colon and rectal cancer respectively. After accounting for patient and tumour characteristics, survival outcomes demonstrated significant geographical variation.Conclusions National linked administrative datasets have the ability to provide real-world representation of the treatments and outcomes for patients with cancer. In a Scottish population of curative patients with CRC, there was significant variation in survival depending on sex and geography.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by Cancer Research UK (CRUK) Ref:C23434/A23706 "Creating a UK Colorectal Cancer Intelligence Hub"Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was approved under the favourable ethics opinion of the East of Scotland NHS Research Ethics Service for the secondary analysis of Public Health Scotland data within the National Safe Haven for UK based researchers and also had South West Central Bristol Research Ethics Committee ethical approval for the larger project of which it is part (18/SW/0134). The the of the data was approved by the Public Benefit Privacy Panel for Health and Social Care (project number 1718-0026).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in this project are not available for re-use.